OTC · Financial Statements
InNexus Biotechnology, Inc. (IXSBF) Financial Statements
$0.00
OTC: IXSBF
Market Cap $12627
Overview Financials Dividend InNexus Biotechnology, Inc. most recently reported annual revenue of $0, a net loss of $7.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2005 2006 2007 2008 2009 Revenue $0 $0 $0 $0 $0 Operating Profit $-3.0M $-5.0M $-6.0M $-7.0M $-4.0M Net Profit $-3.0M $-5.0M $-6.0M $-8.0M $-7.0M EPS $-0.12 $-0.13 $-0.11 $-0.11 $-0.07 Op Margin -5758.2% -33603.6% -565567.3% — —
Balance Sheet (USD)
Metric 2005 2006 2007 2008 2009 Total Assets $1.0M $7.0M $6.0M $5.0M $3.0M Total Liabilities $0 $2.0M $2.0M $7.0M $9.0M Cash $1.0M $3.0M $3.0M $0 $0 Borrowings $0 $0 $0 $3.0M $3.0M
Cash Flow (USD)
Metric 2005 2006 2007 2008 2009 Operating Cash Flow $-2.0M $-2.0M $-8.0M $-3.0M $-2.0M Investing Cash Flow $-1.0M $-4.0M $3.0M $-2.0M $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $1.0M $2.0M $0 $-3.0M $0 Free Cash Flow $-3.0M $-3.0M $-10.0M $-3.0M $-2.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.15 FCF Yield -9041.78% Quick Ratio 0.00 Interest Coverage -1.41 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .